InsideTrading SEC Form 4 insider trades

Stocks

PHAT Phathom Pharmaceuticals, Inc.

Healthcare · Market cap: $490.3M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $415.1K, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $35.4K 2023-Q1: bought $73.6K, sold $77.3K 2023-Q2: bought $191.2K, sold $74.5K 2023-Q3: bought $0, sold $0 2023-Q4: bought $58.6K, sold $126.3K 2024-Q1: bought $0, sold $30.2M 2024-Q2: bought $0, sold $38.1K 2024-Q3: bought $0, sold $575.1K 2024-Q4: bought $180.3K, sold $19.3K 2025-Q1: bought $44.2K, sold $221.3K 2025-Q2: bought $216.9K, sold $16.7K 2025-Q3: bought $0, sold $19.7K 2025-Q4: bought $0, sold $7.1K 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $415.1K) Sold, below the line (largest quarter $30.2M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$415.1K$0
2022-Q3$0$0
2022-Q4$0$35.4K
2023-Q1$73.6K$77.3K
2023-Q2$191.2K$74.5K
2023-Q3$0$0
2023-Q4$58.6K$126.3K
2024-Q1$0$30.2M
2024-Q2$0$38.1K
2024-Q3$0$575.1K
2024-Q4$180.3K$19.3K
2025-Q1$44.2K$221.3K
2025-Q2$216.9K$16.7K
2025-Q3$0$19.7K
2025-Q4$0$7.1K
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$1.2M21 buy days
Sold$31.4M26 sell days
Net insider flow-$30.2Mnet selling · 5 years
Latest trade2025-11-03Breedlove Robert Charles
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2025-11-03 Sell Breedlove Robert Charles Other officer 524 $13.51 $7.1K 1
2025-09-05 Sell Breedlove Robert Charles Other officer 461 $12.09 $5.6K 1
2025-07-16 Sell Breedlove Robert Charles Other officer 1,692 $8.36 $14.1K 1
2025-05-21 Buy Topper James N Director 3,780 $3.86 $14.6K 1
2025-05-14 Buy Topper James N Director 6,300 $3.32 $20.9K 1
2025-05-13 Buy Topper James N Director 1,120 $3.16 $3.5K 1
2025-05-12 Buy Topper James N Director 12,601 $3.04 $38.3K 1
2025-05-09 Buy Topper James N Director 35,602 $3.22 $114.5K 2
2025-05-07 Buy Parikh Asit Director 5,000 $2.40 $12.0K 1
2025-05-06 Buy Parikh Asit Director 5,000 $2.60 $13.0K 1
2025-04-07 Sell Henderson Molly CFO 3,678 $4.55 $16.7K 1
2025-03-13 Buy Parikh Asit Director 10,000 $4.42 $44.2K 1
2025-01-21 Sell Curran Terrie CEO 19,109 $6.59 $125.9K 1
2025-01-21 Sell Nabulsi Azmi COO 7,886 $6.59 $52.0K 1
2025-01-21 Sell Henderson Molly CFO 6,583 $6.59 $43.4K 1
2024-12-19 Sell Henderson Molly CFO 1,291 $8.00 $10.3K 1
2024-12-19 Sell Nabulsi Azmi COO 1,118 $8.00 $8.9K 1
2024-12-13 Buy KARBE FRANK Director 12,500 $7.93 $99.1K 1
2024-12-13 Buy Parikh Asit Director 10,000 $8.12 $81.2K 1
2024-07-15 Sell Curran Terrie CEO 33,848 $11.72 $396.7K 1
2024-07-15 Sell Nabulsi Azmi COO 10,901 $11.72 $127.8K 1
2024-07-15 Sell Henderson Molly CFO 4,325 $11.72 $50.7K 1
2024-04-08 Sell Henderson Molly CFO 3,435 $11.10 $38.1K 1
2024-03-22 Sell Curran Terrie CEO 16,851 $9.11 $153.5K 1
2024-01-24 Sell TAKEDA PHARMACEUTICAL CO LTD 10% owner 3,703,703 $8.10 $30.0M 1
2024-01-19 Sell Henderson Molly CFO 6,307 $7.75 $48.9K 1
2023-11-20 Sell Henderson Molly CFO 2,127 $7.24 $15.4K 1
2023-11-08 Buy Parikh Asit Director 2,500 $7.80 $19.5K 1
2023-11-07 Buy Parikh Asit Director 4,000 $7.76 $31.0K 1
2023-11-06 Buy Parikh Asit Director 1,000 $8.04 $8.0K 1
2023-11-01 Sell Henderson Molly CFO 12,492 $8.88 $110.9K 2
2023-06-02 Sell Henderson Molly CFO 1,960 $11.41 $22.4K 1
2023-05-22 Sell Henderson Molly CFO 2,110 $12.87 $27.2K 1
2023-04-11 Buy Nabulsi Azmi COO 10,000 $8.26 $82.6K 1
2023-04-10 Buy Parikh Asit Director 1,000 $7.55 $7.6K 1
2023-04-06 Buy Curran Terrie CEO 12,919 $7.82 $101.0K 1
2023-04-06 Sell Henderson Molly CFO 3,439 $7.27 $25.0K 1
2023-03-01 Sell Henderson Molly CFO 2,032 $8.53 $17.3K 1
2023-03-01 Sell Curran Terrie CEO 1,436 $8.54 $12.3K 1
2023-02-13 Buy Parikh Asit Director 5,000 $7.73 $38.6K 1
2023-01-20 Sell Curran Terrie CEO 5,821 $8.20 $47.7K 1
2023-01-12 Buy Parikh Asit Director 5,000 $7.00 $35.0K 1
2022-11-21 Sell Henderson Molly CFO 2,159 $9.60 $20.7K 1
2022-11-21 Sell Curran Terrie CEO 1,526 $9.60 $14.6K 1
2022-05-16 Buy Nabulsi Azmi COO 20,000 $8.16 $163.2K 1
2022-05-13 Buy Curran Terrie CEO 20,500 $7.41 $151.9K 1
2022-05-12 Buy Parikh Asit Director 12,500 $8.00 $100.0K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
TAKEDA PHARMACEUTICAL CO LTD 10% owner $0 $30.0M 2024-01-24
Curran Terrie CEO $252.9K $750.8K 2025-01-21
Henderson Molly CFO $0 $447.0K 2025-04-07
Nabulsi Azmi COO $245.8K $188.7K 2025-01-21
Parikh Asit Director $390.2K $0 2025-05-07
Topper James N Director $191.9K $0 2025-05-21
KARBE FRANK Director $99.1K $0 2024-12-13
Breedlove Robert Charles Other officer $0 $26.8K 2025-11-03

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2023-04-06 → 2023-04-11 3 $191.2K 55 +58.6% (+55.4% raw)+60.2% (+68.7% raw)+21.2% (+20.1% raw) closed
2022-05-12 → 2022-05-16 3 $415.1K 61 -19.5% (-28.4% raw)+22.3% (+32.1% raw)+14.1% (+18.9% raw) closed
2019-10-29 3 $40.2M 43 -25.9% (-22.8% raw)-45.6% (-53.4% raw)-46.3% (-50.1% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.